Characterizing Effects of Erenumab on Patients with Menstrually-Related Migraines

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Migraine
  • Age: Between 18 - 55 Years
  • Gender: Female
  • Other Inclusion Criteria:
    1. Female patients between age 18 – 55 treated at NYU Langone Health
    2. Diagnosis of migraine headaches
    3. Current or prior use of erenumab for migraine treatment, for at least 3 consecutive months

You may not be eligible for this study if the following are true:

    1. Does not meet the inclusion criteria



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.